To make cell therapies widely available, efficient manufacturing process for large quantities of living human stem cells are needed. Conventional 2D culture of adherent cells in T-flasks or cell stacks is inefficient, cost, and labor intensive.
At Minaris, our team of experts have established efficient large-scale cell product processes using 3D bioreactors to expand adherent and non-adherent cells, allowing our team to design service packages and tailor-made solutions for your specific manufacturing needs.
The benefits of using 3D bioreactors include:
Download our brochure to learn about the implications of utilizing 3D bioreactor processes in your allogeneic cell therapy.